What is Tribal Diagnostics?
Tribal Diagnostics operates as a premiere diagnostics lab, specializing in a comprehensive suite of testing services. Their expertise spans toxicology, employee drug screens, blood analysis, pharmacogenomics, and cytology testing. The company's focus on these critical health and safety areas positions it as a key player in the healthcare diagnostics sector, serving a vital role in both clinical and occupational health.
How much funding has Tribal Diagnostics raised?
Tribal Diagnostics has raised a total of $3.4M across 2 funding rounds:
Debt
$150K
Other Financing Round
$3.2M
Debt (2020): $150K with participation from PPP
Other Financing Round (2023): $3.2M led by Raven Indigenous Capital Partners
Key Investors in Tribal Diagnostics
Raven Indigenous Capital Partners
Raven Indigenous Capital Partners is an investor focused on supporting Indigenous-led businesses and initiatives. Their involvement suggests a strategic alignment with Tribal Diagnostics' mission and potential for growth within sectors that benefit from Indigenous expertise or community engagement.
What's next for Tribal Diagnostics?
The recent major strategic investment suggests Tribal Diagnostics is poised for significant expansion and operational enhancement. This capital infusion is likely to fuel advancements in their testing methodologies, broaden their service offerings, and potentially expand their geographic reach. The company's trajectory indicates a move towards scaling its enterprise-level operations, solidifying its market presence and capabilities in specialized diagnostic services.
See full Tribal Diagnostics company page
